Catalent widens its ambitious expansion at Baltimore airport site, adding more viral vector suites
A Catalent site outside of BWI Airport in Baltimore is getting an upgrade.
The Somerset, NJ-based manufacturer will pump $230 million into the site in order to add three more viral vector manufacturing suites and associated services in Harmans, MD, to meet an increase in demand.
Right now, the site includes a facility with 10 commercial-scale manufacturing suites. A second facility is currently being built as part of another $130 million project Catalent initiated in 2020, and will add another five manufacturing suites that, if all goes according to plan, will be operational in mid-2022.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 147,500+ biopharma pros reading Endpoints daily — and it's free.